Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
06:59am, Tuesday, 20'th Jan 2026
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer.
2 Dividend Stocks to Buy and Hold For 10 Years
01:58pm, Monday, 19'th Jan 2026
These drugmakers can perform well despite competition and patent cliffs facing them. Both have excellent dividend programs and have increased their payouts at a good clip.
2 Buffett Stocks to Load Up On—And 1 to Ditch
08:20am, Monday, 19'th Jan 2026
Warren Buffett made some substantial changes to the Berkshire Hathaway Inc. NYSE: BRK.B portfolio in the first quarters of 2025, including selling off some $4 billion in Apple Inc. NASDAQ: AAPL shar
Bristol Myers Squibb Company (NYSE:BMY) Given Average Recommendation of “Hold” by Brokerages
02:24am, Sunday, 18'th Jan 2026
Shares of Bristol Myers Squibb Company (NYSE: BMY - Get Free Report) have been given a consensus recommendation of "Hold" by the twenty-one analysts that are currently covering the stock, MarketBeat r
Bristol Myers Squibb (BMY) Suffers a Larger Drop Than the General Market: Key Insights
06:46pm, Friday, 16'th Jan 2026
In the most recent trading session, Bristol Myers Squibb (BMY) closed at $55.26, indicating a -2.4% shift from the previous trading day.
Bristol Myers Squibb Company $BMY Shares Purchased by Fjarde AP Fonden Fourth Swedish National Pension Fund
05:00am, Friday, 16'th Jan 2026
Fjarde AP Fonden Fourth Swedish National Pension Fund raised its position in shares of Bristol Myers Squibb Company (NYSE: BMY) by 7.8% in the third quarter, according to the company in its most recen
Conning Inc. Reduces Position in Bristol Myers Squibb Company $BMY
04:46am, Thursday, 15'th Jan 2026
Conning Inc. decreased its holdings in Bristol Myers Squibb Company (NYSE: BMY) by 2.1% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 701,91
Analyzing Bristol Myers Squibb (NYSE:BMY) & VivoSim Labs (NASDAQ:VIVS)
02:16am, Thursday, 15'th Jan 2026
VivoSim Labs (NASDAQ: VIVS - Get Free Report) and Bristol Myers Squibb (NYSE: BMY - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies
Will Positive Data on Camzyos Strengthen BMY's Cardiovascular Portfolio?
01:10pm, Wednesday, 14'th Jan 2026
BMY reports positive late-stage data for Camzyos in adolescents with oHCM, expanding its cardiovascular outlook amid pipeline setbacks and rising competition.
Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock
10:01am, Tuesday, 13'th Jan 2026
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
Bristol-Myers Squibb Company (BMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
03:45pm, Monday, 12'th Jan 2026
Bristol-Myers Squibb Company (BMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Tempus Shares Jump After Strong Preliminary 2025 Results
01:35pm, Monday, 12'th Jan 2026
Tempus AI (TEM) shares rose about 10% on Monday after the company filed preliminary, unaudited results showing roughly $1.27 billion in 2025 revenue.The filing
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Camzyos--BMS Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos in Adolescents with Symptomatic oHCM.
Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth
05:47am, Monday, 12'th Jan 2026
Tempus AI (NASDAQ: TEM) stock rose after releasing preliminary Q4 and 2025 results, with revenue of $1.27B in 2025 and $367M in Q4.
Market Today: Meta taps nuclear; GM books $6B EV charge
05:35pm, Friday, 09'th Jan 2026
Stock News California billionaire tax splits tech leaders: Nvidia (NVDA) CEO Jensen Huang said he's âfineâ with a proposed one-time 5% California wealth tax
